Cabaletta Bio (CABA) Other Accumulated Expenses (2018 - 2026)
Cabaletta Bio (CABA) posted quarterly Other Accumulated Expenses of $80000.0 for Q4 2025, up 100.0% year-over-year from $40000.0 in Q4 2024, and up 166.67% quarter-over-quarter from $30000.0 in Q3 2025.
Analysis
Cabaletta Bio (CABA) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
Cabaletta Bio's Other Accumulated Expenses history runs 8 years deep, the most recent figure standing at $80000.0 for Q4 2025.
- In Q4 2025, Other Accumulated Expenses rose 100.0% year-over-year to $80000.0; the TTM figure through Dec 2025 stood at $80000.0 (up 100.0% YoY), while the FY2025 annual figure was $80000.0, up 100.0% from the prior year.
- Other Accumulated Expenses for Q4 2025 stood at $80000.0, up from $30000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $83000.0 in Q1 2021, with the low at $16000.0 in Q2 2025.
- The 5-year median for Other Accumulated Expenses is $43500.0 (2021), against an average of $44150.0.
- The sharpest annual moves came in 2021 and 2025: Other Accumulated Expenses sank 62.86% in 2021, then jumped 100.0% in 2025.
- Cabaletta Bio's Other Accumulated Expenses stood at $54000.0 in 2021, then decreased by 27.78% to $39000.0 in 2022, then climbed by 2.56% to $40000.0 in 2023, then changed by 0.0% to $40000.0 in 2024, then surged by 100.0% to $80000.0 in 2025.
- Business Quant data shows CABA's Other Accumulated Expenses at $80000.0 in Q4 2025, $30000.0 in Q3 2025, and $16000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Cabaletta Bio | 522.26 Mn | 522.26 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 60,000.00 |
| Dec 31, 2025 | 80,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Mar 31, 2025 | 50,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 40,000.00 |
| Sep 30, 2023 | 30,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 39,000.00 |
| Sep 30, 2022 | 71,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Mar 31, 2022 | 58,000.00 |
| Dec 31, 2021 | 54,000.00 |
| Sep 30, 2021 | 52,000.00 |
| Jun 30, 2021 | 47,000.00 |